Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 2
2007 1
2008 1
2013 2
2014 4
2015 3
2016 5
2017 3
2018 1
2019 2
2020 4
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean dong yu park (80 results)?
Discovery of Small Molecule Bak Activator for Lung Cancer Therapy.
Park D, Anisuzzaman ASM, Magis AT, Chen G, Xie M, Zhang G, Behera M, Sica GL, Ramalingam SS, Owonikoko TK, Deng X. Park D, et al. Theranostics. 2021 Jul 25;11(17):8500-8516. doi: 10.7150/thno.60349. eCollection 2021. Theranostics. 2021. PMID: 34373755 Free PMC article.
EZH2 has a non-catalytic and PRC2-independent role in stabilizing DDB2 to promote nucleotide excision repair.
Koyen AE, Madden MZ, Park D, Minten EV, Kapoor-Vazirani P, Werner E, Pfister NT, Haji-Seyed-Javadi R, Zhang H, Xu J, Deng N, Duong DM, Pecen TJ, Frazier Z, Nagel ZD, Lazaro JB, Mouw KW, Seyfried NT, Moreno CS, Owonikoko TK, Deng X, Yu DS. Koyen AE, et al. Among authors: park d. Oncogene. 2020 Jun;39(25):4798-4813. doi: 10.1038/s41388-020-1332-2. Epub 2020 May 26. Oncogene. 2020. PMID: 32457468 Free PMC article.
Mcl-1 Interacts with Akt to Promote Lung Cancer Progression.
Chen G, Park D, Magis AT, Behera M, Ramalingam SS, Owonikoko TK, Sica GL, Ye K, Zhang C, Chen Z, Curran WJ, Deng X. Chen G, et al. Among authors: park d. Cancer Res. 2019 Dec 15;79(24):6126-6138. doi: 10.1158/0008-5472.CAN-19-0950. Epub 2019 Oct 29. Cancer Res. 2019. PMID: 31662324 Free PMC article.
Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy.
Xu K, Park D, Magis AT, Zhang J, Zhou W, Sica GL, Ramalingam SS, Curran WJ, Deng X. Xu K, et al. Among authors: park d. Mol Cancer. 2019 Apr 10;18(1):85. doi: 10.1186/s12943-019-1012-4. Mol Cancer. 2019. PMID: 30971271 Free PMC article.
Targeting Mcl-1 enhances DNA replication stress sensitivity to cancer therapy.
Chen G, Magis AT, Xu K, Park D, Yu DS, Owonikoko TK, Sica GL, Satola SW, Ramalingam SS, Curran WJ, Doetsch PW, Deng X. Chen G, et al. Among authors: park d. J Clin Invest. 2018 Jan 2;128(1):500-516. doi: 10.1172/JCI92742. Epub 2017 Dec 11. J Clin Invest. 2018. PMID: 29227281 Free PMC article.
Theranostic Probes for Cancer Imaging.
Wang F, Zhu L, Yang K, Park D. Wang F, et al. Among authors: park d. Contrast Media Mol Imaging. 2017 Oct 18;2017:1863803. doi: 10.1155/2017/1863803. eCollection 2017. Contrast Media Mol Imaging. 2017. PMID: 29114172 Free PMC article. No abstract available.
Modulation of Bax and mTOR for Cancer Therapeutics.
Li R, Ding C, Zhang J, Xie M, Park D, Ding Y, Chen G, Zhang G, Gilbert-Ross M, Zhou W, Marcus AI, Sun SY, Chen ZG, Sica GL, Ramalingam SS, Magis AT, Fu H, Khuri FR, Curran WJ, Owonikoko TK, Shin DM, Zhou J, Deng X. Li R, et al. Among authors: park d. Cancer Res. 2017 Jun 1;77(11):3001-3012. doi: 10.1158/0008-5472.CAN-16-2356. Epub 2017 Apr 5. Cancer Res. 2017. PMID: 28381544 Free PMC article.
25 results